RBI
BMRN icon

Raiffeisen Bank International’s BioMarin Pharmaceuticals BMRN Stock Holding History

Raiffeisen Bank International’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.8K Hold
696
– – ﹤0.01% 607
2026
Q1 		$39.3K Hold
696
– – ﹤0.01% 585
2025
Q4 		$34.5K Hold
696
– – ﹤0.01% 577
2025
Q3 		$37.7K Buy
+696
New +$39.8K ﹤0.01% 572

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AIM
ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

Raiffeisen Bank International's BMRN Position: Q2 2026 in Review

Raiffeisen Bank International held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 14,000 shares worth $807K. The position accounts for 0.01% of the portfolio, ranked #440.

Raiffeisen Bank International first reported a position in BMRN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.56M in Q1 2025. 272 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Raiffeisen Bank International held 14,000 shares of BioMarin Pharmaceuticals worth $807K as of Q2 2026.
  • Raiffeisen Bank International left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
  • BioMarin Pharmaceuticals made up 0.01% of Raiffeisen Bank International's portfolio in Q2 2026, its #440 holding.
  • Raiffeisen Bank International first reported a position in BioMarin Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Raiffeisen Bank International's BioMarin Pharmaceuticals position peaked at $1.56M in Q1 2025.
  • 272 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.